Cat.#: ACPP-1394
| Despition | 3(2) 5-Bisphosphate Nucleotidase 1 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 90% (SDS-PAGE) |
| Form | Sterile Filtered clear solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1326 | Galectin 3 Blocking Peptide (AC1326) | 250 µg | inquiry |
| ACPP-1379 | Human OLFM1 Protein (AC1379) | 2 µg | inquiry |
| ACPP-1754 | Human VEGFC Protein, Sf9 (AC1754) | 2 µg | inquiry |
| ACPP-1507 | Human SDC4 Protein (AC1507) | 2 µg | inquiry |
| ACPP-1214 | Ki67 Blocking Peptide (AC1214) | 250 µg | inquiry |
| ACPP-1119 | CD56 Blocking Peptide (AC1119) | 250 µg | inquiry |
| ACPP-1841 | Human DDAH1 Protein (AC1841) | 5 µg | inquiry |
| ACPP-1735 | Human BEST1 Protein (AC1735) | 5 µg | inquiry |
| ACPP-1834 | Human BAALC Protein (AC1834) | 2 µg | inquiry |
| ACPP-1552 | Human CDNF Protein (AC1552) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.